Recurrent Thyroid Cancer Completed Phase 2 Trials for Decitabine (DB01262)

Also known as: Thyroid cancer recurrent

IndicationStatusPhase
DBCOND0028815 (Recurrent Thyroid Cancer)Completed2
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT00085293Decitabine in Treating Patients With Metastatic Papillary Thyroid Cancer or Follicular Thyroid Cancer Unresponsive to Iodine I 131Treatment